Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bixi Zhong"'
Autor:
Xiaofei Zhang, Tingting Cong, Lei Wei, Bixi Zhong, Xiaowo Wang, Jin Sun, Shuxia Wang, Meng Michelle Xu, Ping Zhu, Hong Jiang, Jianwei Wang
Publikováno v:
Haematologica, Vol 107, Iss 10 (2022)
Hematopoietic stem cells (HSC) give rise to the cells of the blood system over the whole lifespan. N6-methyladenosine (m6A), the most prevalent RNA modification, modulates gene expression via the processes of “writing” and “reading”. Recent s
Externí odkaz:
https://doaj.org/article/cd861cef68044b9cb2a5c5a555d16b47
Autor:
Xiaofei, Zhang, Tingting, Cong, Lei, Wei, Bixi, Zhong, Xiaowo, Wang, Jin, Sun, Shuxia, Wang, Meng Michelle, Xu, Ping, Zhu, Hong, Jiang, Jianwei, Wang
Publikováno v:
Haematologica. 107(10)
Hematopoietic stem cells (HSC) give rise to the cells of the blood system over the whole lifespan. N6-methyladenosine (m6A), the most prevalent RNA modification, modulates gene expression via the processes of "writing" and "reading". Recent studies s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9aa910edf0d5e7397b504bfab7237754
https://pubmed.ncbi.nlm.nih.gov/35112556
https://pubmed.ncbi.nlm.nih.gov/35112556
Autor:
Wei Zhang, Jiaqi Li, Haochen Wang, Xiaowo Wang, Hairong Lv, Bixi Zhong, Zhen Xie, Xianglin Zhang, Lei Wei
Publikováno v:
Briefings in Bioinformatics
Detecting cancer signals in cell-free DNA (cfDNA) high-throughput sequencing data is emerging as a novel noninvasive cancer detection method. Due to the high cost of sequencing, it is crucial to make robust and precise predictions with low-depth cfDN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c13e921fc59c7707c7faa9011f72e2
https://doi.org/10.1093/bib/bbab250
https://doi.org/10.1093/bib/bbab250
Autor:
Rong Qiao, Hanwen Xu, Xiaowo Wang, Bixi Zhong, Jin Gu, Wei Zhang, Lei Wei, Xianglin Zhang, Xuegong Zhang
Quantifying cell proportions, especially for rare cell types in some scenarios, is of great value in tracking signals associated with certain phenotypes or diseases. Although some methods have been proposed to infer cell proportions from multicompone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfdfa6afedfcdb1286472a3c11ba71bd
https://doi.org/10.1101/2021.04.02.438149
https://doi.org/10.1101/2021.04.02.438149
Autor:
Jiaqi Li, Juhong Liu, Hairong Lv, Hanwen Xu, Jia-Qi Huang, Xiaowo Wang, Shuying He, Bixi Zhong, Yu Liu, Lei Wei, Wei Zhang
Publikováno v:
Bioinformatics (Oxford, England).
Motivation Cell-free DNA (cfDNA) is gaining substantial attention from both biological and clinical fields as a promising marker for liquid biopsy. Many aspects of disease-related features have been discovered from cfDNA high-throughput sequencing (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06a109944a0962c40657b28d0dcdabf
https://pubmed.ncbi.nlm.nih.gov/34042972
https://pubmed.ncbi.nlm.nih.gov/34042972
Autor:
Lei Wei, Haochen Wang, Hairong Lv, Wei Zhang, Xiaowo Wang, Xianglin Zhang, Zhen Xie, Jiaqi Li, Bixi Zhong
Detecting cancer signals in cell-free DNA (cfDNA) high-throughput sequencing data is emerging as a novel non-invasive cancer detection method. Due to the high cost of sequencing, it is crucial to make robust and precise prediction with low-depth cfDN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a24792cb52b56af978f2751689d01875
https://doi.org/10.1101/2021.01.12.426440
https://doi.org/10.1101/2021.01.12.426440
Publikováno v:
Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 35(12)
With the development of liquid biopsy technology, plasma cell-free DNA (cfDNA) becomes one of the research hotspots. Whole-genome bisulfite sequencing of plasma cell-free DNA has shown great potential medical applications such as cancer detection. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ca5931fd31016adfdcd72c068a0e9b8a
https://pubmed.ncbi.nlm.nih.gov/31880136
https://pubmed.ncbi.nlm.nih.gov/31880136
BackgroundRecently, liquid biopsy for cancer detection has pursued great progress. However, there are still a lack of high quality markers. It is a challenge to detect cancer stably and accurately in plasma cell free DNA (cfDNA), when the ratio of ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf7b20fbcf251d5824ae903f3cb901f0
https://doi.org/10.1101/651497
https://doi.org/10.1101/651497